医学修复学——现代医学重要支撑学科

doi:10.3877/cma.j.issn.2095-1221.2017.01.001

随着医学快速发展，现已呈现为临床医学、预防医学、康复医学、修复医学或医学修复学四大发展方向和分支。医学修复学作为采用修复策略治疗和预防人类疾病和损害以及衰老导致的机体结构和功能障碍的医学学科体系正在受到医学界越来越多的关注，尤其是细胞治疗技术和生物工程技术正在催化这一学科体系加快发展。本文概述其发展概况、修复机制、学科基本概念和涵盖范围、加速推动其发展的举措，并提出"医学修复学是医学发展的重要方向，是现代医学学科体系的四驾马车之一"。

关键词: 修复, 策略, 机制, 组织疗法, 生物技术

With the rapid development of the medicine, it has shown four development directions and branches including clinical medicine, preventive medicine, rehabilitation medicine,and restorative medicine or medical restoratology. Medical restoratology has been paid more and more attention from the medical community, because it has as a medical disciplinary system been treating and preventing dysfunction of both human body structure and functions resulting from disease, damage as well as aging through restorative strategies. Especially cell therapy technology and bio-engineering technology are accelerating the development of this disciplinary system. This review summarizes its development process, restorative mechanism, the basic concepts and coverage of the discipline, measures accelerating its development, and concept that "medical restoratology is an important direction of medical development, and one of the four carriages in modern medical discipline system".

Key words: Repair, Strategy, Mechanism, Tissue therapy, Biotechnology

1	劳为德. 修复医学与组织工程[M] . 北京: 化学工业出版社, 2003 .
2	Friedman M. Letter from the editor[J]. J Restor Med, 2012, 1(1):6.
3	Huang H, Chen L, Sanberg PR. Developmental history of neurorestoratology[J]. J Neurorestoratology, 2015 (3):31-38.
4	黄红云. CNS神经修复学[M]. 北京.科学出版社. 2009.
5	Huang H, Raisman G, Sanberg PR, et al. Neurorestoratology New York, Nova Biomedical, 2015.
6	Dimitrijevic MR, BA Kakulas, Vrbova G. Recent achievements in restorative neurology[J]. Basic Biologicalences, 1986.
7	Liberson WT. More on restorative neurosurgery[J]. Electromyogr Clin Neurophysiol, 1987, 27(6-7):323-325.
8	Nicholls JG. Neural repair. Based on a discussion meeting. Kolimbari, Crete, March 1987[J]. J Exp Biol, 1987, 132:1-289.
9	Keith MW, Peckham PH, Thrope GB, et al. Functional neuromuscular stimulation neuroprostheses for the tetraplegic hand[J]. Clin Orthop Relat Res, 1988, (233):25-33.
10	Fernández CI, Soto J, González O, et al. Neurorestorative techniques as experimental approach to Alzheimer disease treatment[J]. Mol Chem Neuropathol, 1995, 24(2-3):241-244.
11	Jiménez-Jiménez FJ, Molina JA. Neuroprotective and neurorestorative therapy in Parkinson's disease[J]. Rev Neurol,1997, 25(Suppl 2):S185-S193.
12	Andres RH, Meyer M, Ducray AD, et al. Restorative neuroscience: concepts and perspectives[J]. Swiss Med Wkly, 2008, 138(11-12):155-172.
13	Huang H, Chen L, Sanberg PR. Clinical achievements, obstacles, falsehoods, and future directions of cell-based neurorestoratology[J]. Cell Transplant, 2012, 21(Suppl 1):S3-S11.
14	International Association of Neurorestoratology. Beijing declaration of international association of neurorestoratology (IANR). Cell Transplant, 2009,18:487.
15	黄红云，陈琳. 神经修复学——21世纪新学科、新理念、新领域[J]. 中国修复重建外科杂志, 2008, 22(4):439-445.
16	Huang H, Chen L. Neurorestorative process, law, and mechanisms[J]. J Neurorestoratology 2015, 3:23-30.
17	Kandul NP, Zhang T, Hay BA, et al. Selective removal of deletion-bearing mitochondrial DNA in heteroplasmic Drosophila[J]. Nat Commun, 2016, 7:13100.
18	Huang H, Chen L, Wang H, et al. Influence of patients' age on functional recovery after transplantation of olfactory ensheathing cells into injured spinal cord injury[J]. Chin Med J, 2003, 116(10):1488-1491.
19	Huang H, Chen L, Xi H, et al. Fetal olfactory ensheathing cells transplantation in amyotrophic lateral sclerosis patients: a controlled pilot study[J]. Clin Transplant, 2008, 22(6):710-718.
20	Raisman G, Carlstedt T, Choi D, et al. Clinical prospects for transplantation of OECs in the repair of brachial and lumbosacral plexus injuries: opening a door[J]. Exp Neurol, 2011, 229(1):168-173.
21	Lima C, Escada P, Pratas-Vital J, et al. Olfactory mucosal autografts and rehabilitation for chronic traumatic spinal cord injury[J]. Neurorehabil Neural Repair, 2010, 24(1):10-22.
22	Mackay-Sim A, Féron F, Cochrane J, et al. Autologous olfactory ensheathing cell transplantation in human paraplegia: a 3-year clinical trial[J]. Brain, 2008, 131(Pt 9):2376-2386.
23	Chen L, Huang H, Xi H, et al. Intracranial transplant of olfactory ensheathing cells in children and adolescents with cerebral palsy: a randomized controlled clinical trial[J]. Cell Transplant, 2010, 19(2):185-191.
24	Mizuno H. Adipose-derived stem and stromal cells for cell-based therapy: current status of preclinical studies and clinical trials[J]. Curr Opin Mol Ther, 2010, 12(4):442-449.
25	Sanberg PR, Eve DJ, Willing AE, et al. The treatment of neurodegenerative disorders using umbilical cord blood and menstrual blood-derived stem cells[J]. Cell Transplant, 2011, 20(1):85-94.
26	Richardson RM, Freed CR, Shimamoto SA, et al. Pallidal neuronal discharge in Parkinson's disease following intraputamenal fetal mesencephalic allograft[J]. J Neurol Neurosurg Psychiatry, 2011, 82(3):266-271.
27	Mendez I, Dagher A, Hong M, et al. Simultaneous intrastriatal and intranigral fetal dopaminergic grafts in patients with Parkinson disease:a pilot study . Report of three cases[J]. J Neurosurg, 2002, 96(3):589-596.
28	Liao GP, Harting MT, Hetz RA, et al. Autologous bone marrow mononuclear cells reduce therapeutic intensity for severe traumatic brain injury in children[J]. Pediatr Crit Care Med, 2015, 16(3):245-255.
29	Walker PA, Harting MT, Shah SK, et al. Progenitor cell therapy for the treatment of central nervous system injury:a review of the state of current clinical trials[J]. Stem Cells Int, 2010, 2010:369578.
30	Karussis D, Karageorgiou C, Vaknin-Dembinsky A, et al. Safety and immunological effects of mesenchymal stem cell transplantation in patients with multiple sclerosis and amyotrophic lateral sclerosis[J]. Arch Neurol, 2010, 67(10):1187-1194.
31	Attar A, Ayten M, Ozdemir M, et al. An attempt to treat patients who have injured spinal cords with intralesional implantation of concentrated autologous bone marrow cells[J]. Cytotherapy, 2011, 13(1):54-60.
32	Freedman MS, Bar-Or A, Atkins HL, et al. The therapeutic potential of mesenchymal stem cell transplantation as a treatment for multiple sclerosis: consensus report of the International MSCT Study Group[J]. Mult Scler, 2010, 16(4):503-510.
33	Forthofer M, Wirth ED. Coordination of a neural tissue transplantation study in patients with posttraumatic syringomyelia[J]. SCI Nurs, 2001, 18(1):19-29.
34	Yang WZ, Zhang Y, Wu F, et al. Human umbilical cord blood-derived mononuclear cell transplantation:case series of 30 subjects with hereditary ataxia[J]. J Transl Med, 2011, 9:65.
35	López-Lozano JJ, Bravo G, Brera B, et al. Long-term follow-up in 10 Parkinson's disease patients subjected to fetal brain grafting into a cavity in the caudate nucleus:the Clinica Puerta de Hierro experience.CPH Neural Transplantation Group[J].Transplant Proc, 1995, 27(1):1395-1400.
36	Appel SH, Engelhardt JI, Henkel JS, et al. Hematopoietic stem cell transplantation in patients with sporadic amyotrophic lateral sclerosis[J]. Neurology, 2008, 71(17):1326-1334.
37	Sharma A, Gokulchandran N, Sane H, et al. Detailed analysis of the clinical effects of cell therapy for thoracolumbar spinal cord injury:an original study[J]. J Neurorestoratology, 2013 1(28):67-71.
38	Han F, Gong D, Yu，et al. Human umbilical cord blood mononuclear cell transplantation for delayed encephalopathy after carbon monoxide intoxication[J]. J Neurorestoratology, 2013 (1):23-29.
39	Sych N, Klunnik M, Ivankova O, et al. Efficacy of fetal stem cells in Duchenne muscular dystrophy therapy[J]. J Neurorestoratology, 2014 (2):37-46.
40	Tsolaki M, Zygouris S, Tsoutsikas V, et al. Treatment with adipose stem cells in a patient with moderate Alzheimer's disease:case report[J]. J Neurorestoratology, 2015 (3):115-120.
41	Huang H, Sun T, Chen L, et al. Consensus of clinical neurorestorative progress in patients with complete chronic spinal cord injury[J]. Cell Transplant, 2014, 23(Suppl 1):S5-17.
42	Qiao L, Huang H, Muresanu D. Clinical neurorestorative progress in Alzheimer's disease[J]. J Neurorestoratology, 2015 (3):1-9.
43	Huang H, Chen L, Huang H. Clinical neurorestorative progress in traumatic brain injury[J]. Drug Design Development Therapy, 2015, 3:57-62.
44	Qiao L, Lu J, Huang H. Clinical neurorestorative progress in stroke[J]. J Neurorestoratology, 2015, (3):63-71.
45	Geng T, Mark VW. Clinical neurorestorative progress in multiple sclerosis[J]. J Neurorestoratology, 2015 (3):83-90.
46	Chen L, Huang H, Wm D, et al. Clinical neurorestorative progress in Parkinson's disease[J]. J Neurorestoratology, 2015 (3):101-107.
47	Chen L, Huang H, Xi H, et al. Clinical neurorestorative progress in amyotrophic lateral sclerosis[J]. J Neurorestoratology, 2015 (3):109-114.
48	Moviglia GA, Varela G, Brizuela JA, et al. Case report on the clinical results of a combined cellular therapy for chronic spinal cord injured patients[J]. Spinal Cord, 2009, 47(6):499-503.
49	Moviglia GA, Moviglia-Brandolino MT, Varela GS, et al. Feasibility, safety, and preliminary proof of principles of autologous neural stem cell treatment combined with T-cell vaccination for ALS patients[J]. Cell Transplant, 2012, 21(Suppl 1):S57-S63.
50	Huang H, Xi H, Chen L, et al. Long-term outcome of olfactory ensheathing cell therapy for patients with complete chronic spinal cord injury[J]. Cell Transplant, 2012, 21(Suppl 1):S23-S31.
51	Tabakow P, Jarmundowicz W, Czapiga BA, et al. Transplantation of autologous olfactory ensheathing cells in complete human spinal cord injury[J]. Cell Transplant, 2013, 22(9):1591-1612.
52	Tabakow P, Raisman G, Fortuna W, et al. Functional regeneration of supraspinal connections in a patient with transected spinal cord following transplantation of bulbar olfactory ensheathing cells with peripheral nerve bridging[J]. Cell Transplant, 2014, 23(12):1631-1655.
53	Riley J, Glass J, Feldman EL, et al. Intraspinal stem cell transplantation in amyotrophic lateral sclerosis: a phase I trial, cervical microinjection, and final surgical safety outcomes[J]. Neurosurgery, 2014, 74(1):77-87.
54	Feldman EL, Boulis NM, Hur J, et al. Intraspinal neural stem cell transplantation in amyotrophic lateral sclerosis: Phase 1 trial outcomes[J]. Ann Neurol, 2014, 75(3):363-373.
55	Mazzini L, Ferrero I, Luparello V, et al. Mesenchymal stem cell transplantation in amyotrophic lateral sclerosis: A Phase I clinical trial[J]. Exp Neurol, 2010, 223(1, SI):229-237.
56	Mazzini L, Gelati M, Profico DC, et al. Human neural stem cell transplantation in ALS: initial results from aphase I trial[J] J Transl Med, 2015,13:17.
57	Seledtsova GV, Rabinovich SS, Belogorodtsev S, et al. Delayed results of transplantation of fetal neurogenic tissue in patients with Consequences of spinal cord trauma[J]. Bull Exp Biol Med, 2010, 149(4):530-533.
58	Huang H, Chen L, Xi H, et al. Olfactory ensheathing cells transplantation for central nervous system diseases in 1,255 patients[J]. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi, 2009, 23(1):14-20.
59	Battistella V, de Freitas GR, da Fonseca LM, et al. Safety of autologous bone marrow mononuclear cell transplantation in patients with nonacute ischemic stroke[J]. Regen Med, 2011, 6(1):45-52.
60	Friedrich MA, Martins MP, Araujo MD, et al. Intra-arterial infusion of autologous bone marrow mononuclear cells in patients with moderate to severe middle cerebral artery acute ischemic stroke[J]. Cell Transplant., 2012, 21(Suppl 1):S13-21.
61	Moviglia GA, Fernandez Viña R, Brizuela JA, et al. Combined protocol of cell therapy for chronic spinal cord injury. Report on the electrical and functional recovery of two patients[J]. Cytotherapy. 2006, 8(3):202-209.
62	Lee JS, Hong JM, Moon GJ, et al. A long-term follow-up study of intravenous autologous mesenchymal stem cell transplantation in patients with ischemic stroke[J]. Stem Cells, 2010, 28(6):1099-1106.
63	Bang OY, Lee JS, Lee PH, et al. Autologous mesenchymal stem cell transplantation in stroke patients[J]. Ann Neurol, 2005, 57(6):874-882.
64	Chen L, Huang HY, Jiang Z, et al. Electromyogram evaluation in 389 patients with amyotrophic lateral sclerosis following olfactory ensheathing cell intracranial transplantation[J]. Journal of Clinical Rehabilitative Tissue Engineering Research, 2008, 12(43):8422-8425.
65	Luan Z, Liu WP, Qu SQ, et al. Treatment of newborns with severe injured brain with transplantation of human neural precursor cells[J]. Zhonghua Er Ke Za Zhi. 2011 Jun;49(6):445-449.
66	Chen L, Xi HT, Huang HY, et al. Multiple cell transplantation based on an intraparenchymal approach for patients with chronic phase stroke[J]. Cell Transplant, 2013, 22(1):S83-S91.
67	Xi HT, Chen L, Huang HY, et al. Preliminary report of multiple cell therapy for patients with multiple system atrophy[J]. Cell Transplant, 2013, 22(1):S93-S99.
68	Chen L, Huang H, Xi H, et al. A prospective randomized double-blind clinical Ttial using a combination of olfactory ensheathing cells and Schwann cells for the treatment of chronic complete spinal cord injuries[J]. Cell Transplant, 2014, 23(Supplement1):S35–S44.
69	Wang S, Cheng H, Dai G, et al. Umbilical cord mesenchymal stem cell transplantation significantly improves neurological function in patients with sequelae of traumatic brain injury[J]. Brain Res, 2013, 1532:76-84.
70	Li JF, Zhang DJ, Geng TC, et al. The potential of human umbilical Cord-Derived mesenchymal stem cells as a novel cellular therapy for multiple sclerosis[J]. Cell Transplant, 2014, 23(1):S113-S122.
71	Wang X, Hu H, Hua R, et al. Effect of umbilical cord mesenchymal stromal cells on motor functions of identical twins with cerebral palsy:pilot study on the correlation of efficacy and hereditary factors[J]. Cytotherapy, 2015, 17(2):224-231.
72	Li P, Cui K, Zhang B, et al. Transplantation of human umbilical cord-derived mesenchymal stems cells for the treatment of Becker muscular dystrophy in affected pedigree members[J]. Int J Mol Med, 2015, 35(4):1051-1057.
73	Zhu H, Poon W, Liu Y, et al. Phase I-II clinical trial assessing safety and efficacy of umbilical cord blood mononuclear cell transplant therapy of chronic complete spinal cord injury[J]. Cell Transplant, 2016. [Epub ahead of print].
74	Chen L, Chen D, Xi HT, et al. Olfactory ensheathing cell neurorestorotherapy for amyotrophic lateral sclerosis patients: benefits from multiple transplantations[J]. Cell Transplant, 2012, 21(1):S65-S77.
75	Knotkova H, Cruciani RA. Non-invasive transcranial direct current stimulation for the study and treatment of neuropathic pain. Methods Mol Biol, 2010, 617:505-515.
76	Strafella AP, Ko JH, Monchi O. Therapeutic application of transcranial magnetic stimulation in Parkinson's disease: the contribution of expectation[J]. Neuroimage, 2006, 31(4):1666-1672.
77	Di Lazzaro V, Dileone M, Pilato F, et al. Repetitive transcranial magnetic stimulation for ALS. A preliminary controlled study[J]. Neurosci Lett, 2006, 408(2):135-140.
78	Pape TL, Rosenow J, Lewis G. Transcranial magnetic stimulation:a possible treatment for TBI[J]. J Head Trauma Rehabil, 2006, 21(5):437-451.
79	Lefaucheur JP. Stroke recovery can be enhanced by using repetitive transcranial magnetic stimulation (rTMS)[J]. Neurophysiol Clin. 2006;36(3):105-115.
80	Lefaucheur JP. The use of repetitive transcranial magnetic stimulation(rTMS)in chronic neuropathic pain[J]. Neurophysiol Clin, 2006, 36(3):117-124.
81	Tyvaert L, Houdayer E, Devanne H, et al. The effect of repetitive transcranial magnetic stimulation on dystonia: a clinical and pathophysiological approach[J]. Neurophysiol Clin, 2006, 36(3):135-143.
82	Fregni F, Otachi PT, Do Valle AA, et al. A randomized clinical trial of repetitive transcranial magnetic stimulation in patients with refractory epilepsy[J]. Ann Neurol, 2006, 60(4):447-455.
83	Nashold BS, Friedman H, Glenn JF, et al. Electromicturition in paraplegia: implantation of a spinal neuroprosthesis[J]. Proc Veterans Adm Spinal Cord Inj Conf, 1971,18:161-165.
84	Collinger JL, Wodlinger B, Downey JE, et al. High-performance neuroprosthetic control by an individual with tetraplegia[J]. Lancet, 2013, 381(9866):557-564.
85	Hochberg LR, Serruya MD, Friehs GM, et al. Neuronal ensemble control of prosthetic devices by a human with tetraplegia[J]. Nature, 2006, 442(799):164-171.
86	Onose G, Grozea C, Anghelescu A, et al. On the feasibility of using motor imagery EEG-based brain-computer interface in chronic tetraplegics for assistive robotic arm control: a clinical test and long-term post-trial follow-up[J]. Spinal Cord, 2012, 50(8):599-608.
87	Bloch J, Bachoud-Lévi AC, Déglon N, , et al. Neuroprotective gene therapy for Huntington's disease, using polymer-encapsulated cells engineered to secrete human ciliary neurotrophic factor: Results of a phase I study[J]. Hum Gene Ther, 2004, 15(10):968-975.
88	Tuszynski MH, Thal L, Pay M, et al. A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease[J]. Nat Med, 2005, 11(5):551-555.
89	国际神经修复学会中国分会暨中国神经修复学会筹委会. 中国神经修复细胞治疗临床规范(2011年第1版)[J/CD]. 中华临床医师杂志（电子版）, 2011, 5(19):5710-5714.
90	Chinese Branch of International Association of Neurorestoratology (IANR); Preparatory Committee ofChinese Association of Neurorestoratology. Standard recommendations for the application of Chinese clinical cell therapy for neurorestoration (2012)[J]. Cell Transplant,2013,22(S1):S5-S10.
91	中国医师协会神经修复学专业委员会暨国际神经修复学会中国分会. 中国神经修复细胞治疗临床应用指南（2015年版）[J/CD].中华细胞与干细胞杂志(电子版), 2016, 6(1):1-7.
92	Huang H, Clinical cell therapy guidelines for neurorestoratiion (China Version 2016)[J]. J Neurorestoratology, 2016, 5:39-46.
93	Feng Y, Sun T, Chen L, et al. Clinical therapeutic guideline of neurorestoration for spinal cord injury (China Version 2016)[J]. J Neurorestoratology, 2017, 5.
94	Scicurious. The BRAIN Initiative: BAM or BUST?[J/OL]. updated April 8, 2013; cited July 9, 2013.Accessed September 19, 2013. URL
95	D'Angelo E. The human brain project[J/OL]. Funct Neurol. 2012;27(4). Accessed October 24, 2013. URL
96	Huang H, Sharma H. Neurorestoratology:one of the most promising new disciplines at the forefront of neuroscience and medicine[J]. J Neurorestoratol, 2013 (1):37-41.
97	Young W, AlZoubi Z, Saberi H, et al. Beijing declaration of international association of neurorestoratology (IANR)[J]. J Neurorestoratology, 2015, 3:121-122.
98	Huang HY, Chen L. Neurorestoratology: a concept and emerging discipline in the treatment of neurological disorders[J]. CNS Neurol Disord Drug Targets, 2016, 15(5):522-525.

[1]	徐志刚, 曹涛, 何亭, 李博奥, 魏婧韬, 张栋梁, 官浩, 杨薛康. 采用抗生素骨水泥治疗糖尿病患者心脏术后胸骨骨髓炎的临床效果观察[J/OL]. 中华损伤与修复杂志(电子版), 2024, 19(06): 498-502.
[2]	林同辉, 杨卫玺. 股前外侧穿支皮瓣在电烧伤治疗中应用的研究进展[J/OL]. 中华损伤与修复杂志(电子版), 2024, 19(06): 526-530.
[3]	王强, 金光哲, 巨积辉, 王凯, 唐晓强, 吕文涛, 程贺云, 杨林, 王海龙. 超声辅助定位下游离臂内侧皮瓣在修复手指创面中的临床应用[J/OL]. 中华损伤与修复杂志(电子版), 2024, 19(05): 393-397.
[4]	关丁丁, 李伟, 孔维诗, 包郁露, 孙瑜. 负载干细胞的光交联蛋白基水凝胶在组织工程中应用的研究进展[J/OL]. 中华损伤与修复杂志(电子版), 2024, 19(05): 447-452.
[5]	张茜柳, 余东升. 医源性牙外伤的发生原因和防治策略[J/OL]. 中华口腔医学研究杂志(电子版), 2024, 18(05): 287-294.
[6]	严华悦, 刘子祥, 周少波. 磷酸烯醇式丙酮酸羧激酶-1在恶性肿瘤中的研究进展[J/OL]. 中华普通外科学文献(电子版), 2024, 18(06): 452-456.
[7]	袁园园, 岳乐淇, 张华兴, 武艳, 李全海. 间充质干细胞在呼吸系统疾病模型中肺组织分布及治疗机制的研究进展[J/OL]. 中华细胞与干细胞杂志(电子版), 2024, 14(06): 374-381.
[8]	王庭宇, 邵联波, 刘珊, 沈振亚. Stanford A 型主动脉夹层相关基因KIF20A 的共表达网络构建及作用靶点分析[J/OL]. 中华细胞与干细胞杂志(电子版), 2024, 14(05): 303-312.
[9]	严虹霞, 王晓娟, 张毅勋. 2 型糖尿病对结直肠癌患者肿瘤标记物、临床病理及预后的影响[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 483-487.
[10]	赵泽云, 李建男, 王旻. 中性粒细胞胞外诱捕网在结直肠癌中的研究进展[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 524-528.
[11]	孙明策, 韩世焕. 海藻酸盐水凝胶支架在颅骨缺损修复中的应用进展[J/OL]. 中华神经创伤外科电子杂志, 2024, 10(05): 310-314.
[12]	陈倩倩, 袁晨, 刘基, 尹婷婷. 多层螺旋CT 参数、癌胚抗原、错配修复基因及病理指标对结直肠癌预后的影响[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(06): 507-511.
[13]	刘琦, 王守凯, 王帅, 苏雨晴, 马壮, 陈海军, 司丕蕾. 乳腺癌肿瘤内微生物组的研究进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(09): 841-845.
[14]	胡云鹤, 周玉焯, 付瑞瑛, 于凡, 李爱东. CHS-DRG付费制度下GB1分组住院费用影响因素分析与管理策略探讨[J/OL]. 中华临床医师杂志(电子版), 2024, 18(06): 568-574.
[15]	徐靖亭, 孔璐. PARP抑制剂治疗卵巢癌的耐药机制及应对策略[J/OL]. 中华临床医师杂志(电子版), 2024, 18(06): 584-588.

阅读次数

全文

摘要

选择文件类型/文献管理软件名称

选择包含的内容

Medical Restoratology—An important supporting discipline of modern medicine

模态框（Modal）标题

选择文件类型/文献管理软件名称

选择包含的内容

Medical Restoratology—An important supporting discipline of modern medicine